Skip to main content
. Author manuscript; available in PMC: 2022 Aug 4.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2022 Apr 13;93(6):637–644. doi: 10.1136/jnnp-2022-329074

Table 3.

Laboratory results using an intention-to-treat analysis pre-KD and post-KD intervention

Baseline (n=64) 3 months (n=59) 6 months (n=57)


Mean±SD Δ Change from baseline P value Δ Change from baseline P value
25-hydroxyvitamin D (ng/mL)    44±17 +11.5±16 <0.001    +12±17 <0.001

Carnitine, free (nmol/mL)    34±8   −3.7±7   0.001   −1.6±11   0.176

Insulin resistance

  Insulin (uIU/mL) 13.3±8.5   −5.2±6.8 <0.001   −4.7±7.7   0.001

  Haemoglobin A1c (%)   5.4±0.6   −0.3±0.4 <0.001   −0.3±0.5 <0.001

Lipid profiles

  Triglycerides (mg/dL)  107±59    −17±45   0.005    −17±47   0.005

  Low-density lipoprotein (LDL) (mg/dL)  127±35    +14±28 <0.001    +10±27   0.007

  High-density lipoprotein (HDL) (mg/dL)    55±13   −0.4±9   0.763   +3±10   0.03

  LDL/HDL   2.4±0.8   +0.3±0.7   0.001   +0.1±0.7   0.172

  Cholesterol (mg/dL)  200±40    +11±32   0.007    +10±31   0.021

Adipo-cytokines

  Leptin (ng/mL) 25.5±15.7 −12.1±11.4 <0.001 −10.6±11.7 <0.001

  Adiponectin (μg/mL) 11.4±7.8   +0.7±3.8   0.162   +1.7±3.9   0.002

Results represent mean±SD as change from baseline to reported time point (eg, 3 months or 6 months on KD).

KD, ketogenic diet.